Transplantation of the liver by Starzl, TE & Iwatsuki, S
T he ultimate therapeutic step in the treatment 
of any terminal hepatic disease is the provision 
.. of a new liver with or without removal of the af-
flicted native organ. The first clinical trial of liver 
transplantation took place in 1963. In the subse-
quent 18 years, more than 400 attempts have been 
made throughout the world, 212 of these by us. 
The historic aspects of both animal and human 
liver transplantation have been summarized in a 
book in which the world literature was brought up 
to date as of the spring of 1969.3 The last complete 
summary of clinical experience was published in 
1979. 4 
KINDS OF OPERATIONS 
Auxiliary Transplantation 
Liver transplantation was first performed and re-
corded by C. S. Welch of Albany, New York, in 
1955. Welch envisioned treating patients who were 
dying of cirrhosis or other non-neoplastic diseases 
for whom the removal of the diseased native liver 
would not be obligatory. With the Welch operation 
. in dogs, the extra canine liver was placed in the 
right paravertebral gutter or the right side of the 
pelvis. Its hepatic arterial supply was derived from 
the aorta or from the iliac arterv. Venous inflow 
was reconstituted by anastomosis of the distal in-
ferior vena cava or a distal iliac vein to the homo-
graft portal vein. Outflow was into the inferior vena 
cava. 
The use of auxiliary homografts for the treat-
ment of benign hepatic disease initially had a spe-
cial attractiveness and still does in the minds of a 
minority of students of liver transplantation. 
Adherents to auxiliary transplantation argue that 
sacrifice of the remaining function of the failing 
reCipient liver could be avoided, providing some 
reserve in the event of poor initial performance by 
the homograft due to ischemia or to a severe but 
reversible rejection. This might be a particularly 
significant advantage in patients with biliary atre-
s~aI because the synthesizing functions of the 
hver are often retained until the terminal stages of 
. this disease. Furthermore, it was initially assumed 
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that the placement of an extra liver would be safer 
and technically less demanding than the or-
thotopic procedure, an assumption that has not 
been validated by actual experience. , 
The results in animals with auxiliary transplan-
tation have been inferior to those with liver re-
placement, partly because coexisting livers have 
the capacity to damage each other to a variable 
degree according to which organ is the" domi-
nant" one. Factors favoring dominance include a 
splanchnic source of the blood for portal venous 
int10w, perfect biliary drainage, optimal total 
hepatic blood flow, and unimpeded venous out-
flow. An auxiliary canine liver graft, which does 
not enjoy these advantages relative to the host 
liver, undergoes rapid atrophy. More recently, 
evidence has been acquired to explain the benefi-
cial effect of perfusing the portal vein with splanch-
nic venous blood. It has been shown that the 
"hepatotrophic factors" in this kind of venous 
blood emanate from the pancreas and that the 
oecipie~ 
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most important constituent is apparently en-
dogenous insulin. 6 Because insulin is largely re-
moved by a single passage through the liver, the 
first organ having access to pancreatic blood would 
deprive the second liver of an adequate supply of 
this hormone. 
Until 1973, clinical auxiliary liver transplanta-
tion had never resulted in the significant prolonga-
tion of recipient life. The results had been so poor 
that the number of attempts at the auxiliary opera-
tion declined virtually to zero. A contributory fac-
tor was that the placement of an extra organ had 
often proved to be more difficult, rather than (ech-
nically simpler, than liver replacement. 
But early in 1973, Fortner of New York City 
lightened the pessimism about auxiliary trans-
plantation by revascularizing a homograft, as 
shown in Figure 35-1, whereby the splanchnic 
blood was directed through the heterotopically lo-
cated liver. Fortner's patient suffered from biliary 
atresia. After operation, the bilirubin level fell to 
;,l vessels left 
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FIG. 35-1. A technique of auxiliary liver 
transplantation in which the homograft .. 
ceives through its portal vein venous blood de- . 
rived from the splanchnic bed. (Starzl, T. E., 
and Putnam, C. W.: Experience in 
Transplantation, pp. 1-553. Philadelphia, W. 
B. Saunders, 1969) 
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FIG. 35-2. Completed orthotopic liver transplan-
tation. (Starzt T. E., and Putnam, C. W.: Experi-
ence in Hepatic Transplantation, pp. 1-553. 
Philadelphia, W. B. Saunders, 1969) 
normal, the native liver underwent marked shrink-
age, and the splenomegaly and hypersplenism 
were relieved. The follow,;up time in the case is 
now more than 8 years. In view of this encourag-
ing experience, additional clinical trials of aux-
iliary transplantation will probably be forthcom-
ing. By September, 1978, Fortner and his associates 
had information on 43 cases, including seven of 
their own. Besides their one unqualified success, 
another of Fortner's patients with biliary obstruc-
tion from an intrahepatic cancer had temporary 
clearing of jaundice but died eight months later. 
The other 41 patients died in less than two months 
from a variety of complications. 2 
Our own view is that auxiliary transplantation 
should be reserved for patients with acute hepatic 
di.sE2se, in which the objective is temporary life-
support during which recovery of the native liver 
can be obtained. The feasibility of this approach 
has been proved in several animal studies but not 
yet in humans. 
Orthotopic Transplantation 
The alternative approach to hepatic transplanta-
tion is liver replacement (or orthotopic transplanta-
!iol'.). With this operation, the diseased host liver 
15 removed, creating a space into which the graft is 
transplanted with as normal an anatomic recon-
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struction as possible (Fig. 35-2). Survival exceed-
ing 10 years has been achieved in both dogs and 
humans. The remarks in succeeding sections per-
tain to the more promising orthotopic transplanta-
tion as opposed to the auxiliary operation dis-
cussed above. 
INDICATIONS FOR HEPATIC 
REPLACEMENT 
No matter what the underlying disease, certain cri-
teria should be met before patients are accepted for 
chronic immunosuppression and transplantation. 
None of the contraindications is absolute, al-
though they may be very strong. For example, 
pre-existing systemic or local infections would 
create highly unfavorable conditions. So would 
diseases or organs other than the liver, such as 
coexisting severe heart disease, or a history of 
sociopathic behavior, which would prevent post-
operative management. From our experience with 
renal transplantation, we have learned that people 
who are more than 45 or 50 years of age frequently 
cannot withstand the rigors of intensive im-
munosuppression. They may develop muscle 
wasting and other physical incapacities, have 
steroid-induced pancreatitis more frequently than 
younger patients, and have a high incidence of a 
" i 
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variety of gastrointestinal complications, includ-
ing gastroduodenal hemorrhage and colonic 
problems. 
From March, 1963, to December, 1977, 141 con~ 
secutive patients were treated with orthotopic liver 
transplantation. The propriety of the various in-
dications for operation has been reviewed on sev-
eral occasions. 3.4 
Benign Disease 
Among the first 141 recipients were 7-1 infants and 
children (Table 35-1). The most common diagnosis 
in this pediatric group was biliary atresia. Chronic 
aggressive hepatitis was a distant second. Eight 
patients had the inborn errors of metabolism 
summarized in the footnote to Table 35-1. It has 
been established that liver-based inborn errors are 
TABLE 35-1. Indications for 
Transplantation 
(1963-1977) in 
Patients < 18 Years 
of Age 
Biliarv Atresia 48 
Chronic Aggressive hepatitis 12 
Inborn metabolic errors U~ 
Hepatoma 3 
Neonatal Hepatitis 2 
Congenital biliary cirrhosis 1 
Total 74 
~lnbom errors: 
Alpha,-antitrypsin deficiency 4 
Wilson's disease 2 
Tyrosinemia 1 
Type IV glycogen storage disease 1 
TABLE 35-2. Indications for 
Transplantation 
(1963-1977) in Patients 
19 to 70 Years of Age 
Chronic aggressive hepatitis 23 
Primary liver malignancy 16 
Alcoholic cirrhosis 15 
Primary biliary cirrhosis 5 
Sclerosing cholangitis 4 
Secondary biliary cirrhosis 2 
Massive hepatic necrosis (B virus) 1 
Budd-Chiari syndrome 1 
Total 67 
permanently rectified by providing livers of nor-
mal phenotypes. t An example is shown in Figure 
35-3 of a boy with Wilson's disease. After liver 
replacement, his serum ceruloplasm rose from un-
detectable to normal levels. For many months, he 
underwent a massive cupruresis, which caused 
corneal copper deposits (Kayser/Fleischer rings) to 
disappear. Pre-existing serious neurologic abnor-
malities were reversed. The patient is still alive 
with normal liver function ten years after trans-
plantation. 
There were 67 adults among the first 141 liver 
recipients. The reasons for proceeding are listed in 
Table 35-2. With the exception of primary hepatic 
malignancies, these indications are all still consid-
ered valid. Excluding hepatic malignancies, the 
most common indications for operation were 
chronic aggressive hepatitis and alcoholic cir-
rhosis. 
In the future, the leading indications for trans-
plantation in adults undoubtedly will be chronic 
aggressive hepatitis and Laennec's cirrhosis. The 
presence of HBsAg viremia is not a contraindica-
tion, because effective postoperative treatment can 
be given with hyperimmune serum.! Cases of cir-
rhosis pose a supreme technical challenge. If results 
are to be improved, candidates need to be selected 
at an earlier time. Too often in the past, recipients 
have been moribund by the time of operation. 
Hepatic Tumors 
Three of our early liver transplantations in chil-
dren and 16 in adults were carried out to treat . 
nonresectable hepatomas, duct-cell carcinomas, 
angiosarcomas, and cholangiocarcinomas. Ten of 
these patients lived beyond three months, but. 
nine of them later developed metastases, which' 
usually contributed to or were primarily responsi-
ble for their deaths after a few months to several 
years. Similarly, the recurrence rate in the 
Cambridge-King's College series in England has 
been 70%.! As more and more such cases have 
been documented, we have had less and less en-
thusiasm for and, indeed, usually avoid .. 
tation for malignancy. 
In spite of this pessimism, there is no 
that some patients with malignancy have be:neJ[lt':; 
ted from liver replacement. Our longest 
who has now lived almost 12 years nn.r:tnne!ra-, 
tively, was cured of an incidental hepatoma 
excised biliary atretic liver. Three of our oaut:u ... 
lived for more than two years in spite 
rences, and one of the three is still alive after 
than five years. 
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FIG. 35-3. The course of a patient with Wilson's disease who received an orthotopic liver 
homograft. Note that the ceruloplasmin rose from undetectable to normal levels and that there 
was a heightened urinary copper excretion for almost a year. In this patient, cyclophosphamide 
and azathioprine were used interchangeably. The deterioration in liver function, which started 
just a month after onset of Wilson's disease, was caused by serum hepatitis (HBsAg). (Groth, 
e. G., et ai.: Transplant. Proc., 5(1):829-833, 1973. Reproduced by permission) 
DONORS 
Procurement 
In most transplantation centers in the United 
States, the criteria of brain death based upon the 
concept of irreversible brain injury have been ac-
cepted for the pronouncement of death. Under 
these conditions and with an ideal cadaveric 
donor, the interval of normothermic ischemic in-
jury is reduced essentiallv to zero, inasmuch as 
dissection prior to remoV'al of the liver or other 
organs can be carried out or even completed in the 
presence of an effective circulation. It is of more 
than passing interest that public acceptance of 
these conditions of organ removal has been wide-
sP.read in America with almost no negative out-
CrIes. 
Recipient Matching 
With the exception of patients with biliary atresia, 
most potential recipients of liver homografts have 
a very brief period of candidacy for transplanta-
tion. If an organ cannot be quickly found, death 
supervenes. Obviously, highly discriminating 
donor selectivity is not practical under these cir-
cumstances, and, for that matter, any selectivity, 
however supportable on immunologic criteria, 
may cost the patient his only chance for treatment. 
It is in the context of such urgency that donor-
recipient matching is conducted. The consequence 
has been that the HLA antigen matches in our 
series have not been good. In 100 consecutive Col-
orado cases, only two patients received livers with 
three or four antigen matches. One of these recip-
ients of a well matched organ died of technical 
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complications 62 days after operation. The other 
died after 11112 months. His graft contained 
chronic rejection. 
Because of urgent need, a number of liver trans-
plantations have been performed despite the pres-
ence in the recipients of cytotoxic antibodies that 
were anti-donor-specific. We have carried out 
more than a dozen liver transplantations under 
these circumstances. There were no examples of 
hyperacute rejection, which almost invariably de-
stroys renal homo grafts under these conditions; 
and, in fact, no unequivocal harmful effects were 
seen later, in contrast with patients without 
CYtotoxic antibodies. ~ We and CaIne and Williams l 
have concluded that the liver is highly privileged 
in confrontations with preformed cytotoxic an-
tibodies. 
Renal homo grafts are also hyperacutely rejected 
if there is a breach of blood-group barriers. We 
proceeded in spite of this adverse factor in 11 liver 
recipients who could not wait for blood group-
compatible organs. The livers did not function well 
in two of the recipients, leading to attempted re-
transplantation and eventual death. The blood vio-
lations in these cases were B to 0 and B to A. The 
excised primary livers had superficial infarcts and 
focal necrosis, but, histopathologically, there was 
nothing to suggest damage by antiblood group 
isoagglutinins. Thus, we will still perform trans-
plantation despite blood group incompatibility, 
although we avoid the condition, if possible. Ex-
cept in the two exceptional cases, the other pa-
tients did not behave differently than those given 
blood group-compatible liversK~ . 
It goes without saying that preformed antibody 
. states should be avoided if at. all possible. How-
ever, the experience cited with both the ABO red 
cell and cytotoxic antibodies makes it clear that 
this kind of positive crossmatch is not an absolute 
contraindication to liver transplantation. 
OPERATIVE PROCEDURES 
Preoperative Preparation 
Prospective liver recipients are generally poor 
risks for a major operation. Those with hepatic 
failure from non-neoplastic disease may even ap-
pear at first evaluation to be hopeless. Paracentesis 
or thoracentesis may be required before anesthesia 
can be contemplated. Transfusions of blood or al-
bumin may be useful for the correction of blood 
volume or other fluid space abnormalities. If fresh 
whole blood, fresh frozen plasma, or platelets are 
judiciously given, some improvement in coagula. ,:';,.,,:101 
tion may be possible. Otherwise, there is USually 
little of real value that can be done to reduce the 
impending operative hazards. 
The surprising ability of these moribund recip- . 
ients to survive such major surgery may be related , 
partly to the troublesome operative bleeding that' 
is almost invariably encountered. The consequent 
necessity for major blood replacement frequently . . 
results in intraoperative exchange transfusions of ' .. 
at least the magnitude reported to be of benefit in 
acute liver insufficiency. The coincidental thera-
peutic effect of massive transfusion, as well as the 
immediate benefits of good hepatic function by 
the transplant, have usually resulted in patients 
returning to the ward in better condition than at . 
the time of their departure. 
Secondary abnormalities of organs other than the . 
liver can sometimes be effectively ameliorated. For 
example, the effects of renal failure secondary to 
the hepatorenal syndrome can be treated with 
artificial kidney. Pulmonary manifestations may 
be improved by simple tracheobronchial toilet, 
particularly if aspiration has occurred. 
The inability to be more specific in preparing 
patients for surgery means that most prospective 
recipients cannot be maintained for very long 
ing a search for a suitable donor. At present, only 
small fraction of patients who might be caln.allWlte, .. 
for liver transplantation can actually be Tr".'''''''Ll. 
because there are no means of providing th~KIKaIw 
analogous to that of the artificial kidney to 
over prospective recipients while an organ 
being found. Until an artificial liver is cte'lI'e14:>DEiQ. 
that provides some of the crucial hepatic tuIlCtl.ORS,' 
liver transplantation will not be able to 
anything close to its true potential. 
Donor Hepatectomy 
In removing a liver for eventual tral1lpDplantcltiClf~ 
the essential steps are to incise the restraining 
aments that bind the organ to the diaphragm 
body wall and to skeletonize the vessels and 
that must be anastomosed to the companion ~u/j!fK" 
tures in the recipient. Figure 35-4 depicts the 
tial steps in this process. Then the portal 
hepatic artery, and common duct are 
(Figure 35-5). Details of the various surgical 
neuvers are described elsewhere.3•4 
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FIG. 35-4. Initial steps in hepatic homograft removal. (A) The falciform and triangular 
ligaments are incised. (B) The suprahepatic vena cava and its tributaries are exposed and 
initially dissected. This is done by entering the raw area formed by divergence of the 
leaves of the falciform and triangular ligaments. A short segment of the left hepatic vein 
(L.H.V.) is usually seen first. (e) After incising the right triangular ligament and the 
anterior leaf of the right coronary ligament, the liver is retracted to the left, exposing the 
bare area of the right lobe. The right adrenal vein, usually the only posterior tributary of 
the retrohepatic vena cava, is ligated and divided. It is then possible to sweep behind the 
vena cava from the diaphragm to the renal veins. If resistance is encountered, it usually 
indicates the presence of extra branches, which must be ligated and divided. R.a.v., 
ligated right adrenal vein. (D) Development of suprahepatic vena caval cuff. At this 
stage, it is desirable to ligate and divide one or more phrenic veins on each side. The 
latter step is not mandatory, but it allows the mobilization of a longer segment for 
subsequent anastomosis. Each length can also be obtained by dissecting off the dia-
phragmatic reflection, as shown. Inset. Cross-sectional appearance of the venous conflu-
ence above the liver as seen from above. The cloaca is formed by the junction of the right 
and left hepatic veins with the inferior vena cava. (Starzl, T. E., and Putnam, C. W.: 
Experience in Hepatic Transplantation, pp. 1-553. Philadelphia, W. B. Saunders, 1969) 
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FIG. 35-5. Dissection of the portal triad. (A) 
The common duct and the gastroduodenal and 
right gastric arteries are tied off and divided. 
Before ligation, it should be determined that 
the common duct communicates freelv with the 
gallbladder by way of the cystic' duct. If 
anomalies are present, failure to observe these 
precautions may lead to accidental bile-duct 
obstruction. (B) The hepatic artery has been 
mobilized far enough so that the anterior sur-
face of the portal vein is uncovered. The coro-
nary vein entering the left side of the p~rtal 
trunk is almost always found; this tributary is 
ligated and divided. (e) The portal vein has 
been freed and the celiac axis mobilized. The 
splenic artery has not yet been ligated and di-
vided. When the liver is removed, all the celiac 
axis is usually retained with the specimen; in. 
children, it may be advisable to include a seg-
ment of aorta as well. (Starz!, T. E., and Put-
-Aorta 
Coronary v. 
nam, C. W.: Experience in Hepatic 
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homografts,l and we have employed an 
(Collins) solution with a composition 
that found in cells. 4 In dogs, the two 
yield comparable results and permit safe n",'C:"1'VlIl'"' 
tion for up to 12 hours. The same applies in 
mans and has permitted the shipment of 
from city to city. The Cambridge surgeons 
cautioned that ischemia or bile left within 
ducts of such livers may cause autolysis and set 
stage for delayed mucosal sloughing and cast 
K~ ;." 
The subsequent preservation of the liver is also of 
vital importance and has been accomplished by 
one or more preservation modalities, depending 
on circumstances, always including organ hy-
pothermia. 3 After removal, quick cooling may 
be accomplished by running a chilled electrolyte 
solution through the portal vein, thus lowering the 
donor organ temperature to about 10 or 15°C, 
which is sufficient for adequate preservation dur-
ing the hour or two required for the vascular anas-
tomoses in the recipient. 
mation. 1 .... _--.. 
Since 1976, methods have been available that 
permit relatively safe and simple storage for longer 
periods. The Cambridge-King's College team has 
used a plasma solution for cold infusion of the. 
Despite the advantages afforded by bralm-·aeip~ 
donors and the improvements in 
hopelessly damaged organs are still 
transplanted. There is at present no reliable way. 
prevent such tragedies by any practical test 
homograft viability. 
1258 
ipient Orthotopic Operation 
of the steps in the recipient are identical or 
to those described above for the donor; 
t .. however, long cuffs of vessels and the duct are left \1JiIl.I! with the patient rather than with the homograft. 11-After removal of the liver, the residual anatomy , consists of cuffs of four cut vessels, the common •. : duct stump (except in biliary atresia), and the raw 
:;" .. areas left by incision of the various hepatic liga-
:I'ments (Fig. 35-6). Reconstruction consists of anas-
~K tomosing the individual vessels to the vessels of 
,it the homograft as quickly as possible. A completed 
~K operation is shown in Figure 35-2. 
D~IK The first anastomosis performed is of the sup-
.:t< rahepatic vena cava. As the vena caval anas-;~ tomoses are constructed, slow infusion of electro-
~"f/ lyte solution is continued through the portal vein. 
,1,;, Air bubbles can be seen floating out of the graft 
!:, (Fig. 35-7). If infusion is not provided during this 
:,,,- time, the air bubbles in the homograft may be 
flushed into the circulation after revascularization. 
, They may then pass through abnormal right-to-Ieft 
venous communications (secondary to liver dis-
ease) and on to the brain. A high incidence of 
cerebral air embolus was encountered in our early 
experience. This was eliminated with the infusion 
technique. 
FIG. 35-6. The operative field after removal of 
the diseased recipient liver. In the illustration, 
an inCision in the diaphragm is shown as part of a 
thoracoabdominal exposure. In more recent 
cases, the chest has not been entered. Cd., 
co~mon duct; H.a., hepatic artery; l.V.C, in-
ferIor vena cava; P. v., portal vein. (Starzl, T E., et 
aL: Surge Gynecol. Obstet., 117:659, 1963) 
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The hilar structures have smaller calibers. In-
creasingly in infants and young recipients, we 
have used microvascular techniques, particularly 
for reconstruction of the hepatic artery and portal 
vein. If such techniques are not used, pediatric 
recipi~nts have a high incidence of thrombosis in 
these vessels. 
Biliary tract reconstruction has caused more 
complications than any other part of the opera-
tion. 1•3•4 In our early experience, one of every three 
recipients subsequently had biliary duct obstruc-
tion or biliary fistula. Even without obstruction or 
fistula, there was a high incidence of bacteremia, 
probably because of constant contamination of the 
biliary ducts through the cholecystoduodenos-
tomies (Fig. 35-8A) that were being used in those 
days. 
Since 1974, we have not used cholecystoduo-
denostomy. We think that duct-to-duct reconstruc-
tion (choledochocholedochostorny) is the best 
method (Figs. 35-2 and 35-8D). If this is not feasible 
(as, for example, in patients with biliary atresia), 
we use cholecystojejunostomy to a Roux-en-Y limb 
(Fig. 35-SB) orcholedochojejunostorny (Fig. 35-SC). 
It is now realized that biliary tract complications 
(especially obstruction) were frequently the cause 
of postoperative jaundice that developed after an 
initial period of bilirubin clearing. When obstruc-
\. 
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Suprahepatic anastomosis 
A. 
tion occurred, it usually was at the narrowed cystic 
duct after cholecystojejunostomy (Fig. 35-8B). 
Once the problem was appreciated, it was found 
safe to secondarily operate, to remove the homo-
graft gallbladder, and to make a conversion to 
choledochojejunostomy (Fig. 35-8C). 
Caine and associates of England have also mod-
ified their practices of biliary reconstruction. 1 
Their presently preferred method is the creation of 
a cloaca between the homograft gallbladder and 
common duct, with anastomosis of the common 
chamber to the recipient common duct. The com-
plexity of this procedure compared to more stan-
dard biliary reconstruction militates against its 
widespread acceptance. 
Splenectomy is usually performed at the time of 
transplantation. The majority of liver recipients 
Low molecular weight 
dext. (Cold) 
~K 
Intrahepatic anastomosis 
Liver 
~KK '"' 
FIG. 35-7. Technique to 
prevent air embolism from 
orthotopic liver homografts. 
(A) Continuous perfusion of 
solution through the portal 
vein as vena caval anas-
tomoses are constructed. (B), 
(C) Escape of air bubbles as 
the anastomoses are com-
pleted. (Starzl. T. E., et aI.: 
Ann. Surg., 187:236-24O,-c-
1978) 
have greatly enlarged spleens and st:ch serious 
hypersplenism that treatment with azathioprine 
and prednisone would be jeopardized without . 
elimination of this factor. 
MANAGEMENT 
Nonimmunologic Complications 
In view of the enormous difficulty of performing 
liver transplantation, it is not surprising that the 
procedure has been followed by a long list of tech-
nical complications. Such complications have been 
responsible for more than half of all deaths 
the first yearK~·· Included have been 
thrombosis, hemorrhage, the unknowing use 
I 
FIG. 35-8. Techniques of 
biliary-duct reconstruction used 
for most of the transplantation 
recipients treated in Colorado. 
(A) Cholecystoduodenostomy. 
This operation is no longer per-
formed. (B) Cholecystojejunos-
tomy. (C) Choledochojejunos-
!: to my after removal of the ~K;K; 
gallbladder. (0) Choledocho-
choledochostomy. Note that if 
possibie, the T:tube is pla~ed 
in the recipient common duct. 
(Starzl, T. E., et al.: Surg. 
Gynecol. Obstet., 142: 487, 1976) 
ischemicaliy damaged grafts, and biliary tract 
obstruction or fistulization, to provide a very in-
complete accounting. These complications have in-
fluen:ed postoperative immunosuppressive man-
agement. For example, better diagnosis and 
management of biliary complications were made 
feasible by an increase in the use of cholangiog-
raphy (percutaneous, retrograde endoscopic, or 
T-tube). 
Another recent change in policy has been the 
~ore frequent use of needle biopsy. Evidence. of 
vl~a~ hepatitis has thereby been obtained in a sur-
pnsmg number of cases. Severe or lethal homo-
graft hepatitis has been caused by HBsAg virus, 
herpes, chicken pox, and adenovirus. An example 
of HBsAg hepatitis is shown in Figure 35-3. Cor-
rect diagnosis helped avoid the lethal error of 
._---------_._-------
T-tu be in reCipient 
common duct 
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intensifying immunosuppression at the very 
moment when the opposite change might have 
been in order. 
The infectious consequences of other major, 
nonimmunologic complications such as vascular 
thromboses and enteric fistulas have been difficult 
to manage under the influence of immunosup-
pression.a.4 
Immunosuppression 
The unique requirement after transplantation of 
any organ is immunosuppression. All of our liver 
recipients have had double drug therapy with a 
cytotoxic agent, azathioprine (which can be used 
interchangeably with cyclophosphamide), and 
prednisone (Figs. 35-3 and 35-9). To the double 
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SGOT 
(I.U.) 
ALKALINE 
PHOSPHATASE 
(ioU.) 
SERUM PROTEIN 
300 
200 
100 
0 
400 
200 
0 
10 
ORTHOTOPIC 
TRANSPLANTATION 
OT 19 4 Y.O. d 
14.3 ~ 17.5 kg. 
(g/IOO ml) 
TOTAL--
ALBUMIN .-------
5 
J ~~-----------------­
" .. ~K: K;-~- .. --- .. -". -J ---, _ .. --.. - -- --~~ .. - .. -- -- - -.. _- ~ ~K~ ~K~~_ ~K~~K~~K~~K:~~~ ~K~~K~~K~ ~K:~~~~ K~~K- ~~~K ~~K ~ K~~K~~K~~ .. 
'Y GLOBULIN 0 
BILIRUBIN 10 
(mg/IOO ml) 5 TOTAL --
CONJUGATED -------- 0 
AZATHIOPRINE 50 
(mg) 25 
0 
~~~fnllr-------~--------------
PREDNISONE 60 (mg) 120 r I r I 
ALG I g 1 EVERY THIRD DAY I TWICE A WEEK 
ORE·OP 0 20 40 60 80 100 4 6 8 10 12 14 16 18 20 22 24 26 
TIME IN DAYS TIME IN MONTHS 
FIG. 35-9. Data on a 4-year-old child with intrahepatic biliary atresia who was treated with 
orthotopic liver transplantation. A very transient rejection occurred after one month. The patient 
underwent almost immediate and complete remission. A late rejection that began on postopera-
tive day 72 was also easily controlled. Note the change in time scale after four months. The child 
survived for 31/2 years post-transplantation, nearly all of that time in good health. The normal 
enzyme values in international units at this age are: alkaline phosphatase, 57 to 151; SGOT, 3 to 
27; and SGPT, 2 to 30. (Starzl, T. E., and Putnam, C. W.: Experience in Hepatic Transplantation, 
pp. 1-553. Philadelphia, W. B. Saunders, 1969) 
TABLE 35 -3. Cases of Liver Replacement at the 
University of Colorado· 
LIVED 
TOTAL 1 YEARt ALIVE NOW 
SERIES 1 
(March, 1963-
July, 1976) 111 31 (28%) 13 (51/z to 12 years) 
SERIES 2 
(July, 1976-
January, 1978) 30 15 (50%) 13 (4-51/z years) 
SERIES 3 
(March, 1978-
April, 1979) 30 10 (33%) 9 (21fz-3 1J2 years) 
• Follow-up is to November, 1981. 
t Deaths between one and six years postoperatively are con-
sidered "late deaths." 
drug regimen, we have often added hel:eI'()lOlIl;O\15 
antilymphocyte globulin (ALG) (Figs. 35-3 
35-9). Irreversible hepatic rejection can usually 
prevented with these techniques. Because of 
there was speculation for a long time that nV,P1"tlM-: 
munosuppression was being systematically 
ticed. 
This view undoubtedly requires some qm"D1p1frgll~1fw 
in light of our recent experience with oaltlellUS 
submitted to frequent homograft biopsy. 
earlier cases, irreversible rejection was not 
mon, but definite rejection was frequently seen 
biopsies and was highly variable in degree, 
ing to the timing of the biopsy. Yet, at ;ml:oosV'J-P· 
many of these homo grafts were free of relb!Ct1Eg~ 
Evidently, intensification of . 
was a justified action to save these livers 
s 
j 
e 
), 
n 
:s 
n 
1-
n 
i-
lethal one if there were any other kind of problem, 
including a technical or mechanical one. 
Thus, the tendency to ascribe most of the high 
mortality after liver transplantation to factors other 
than rejection is probably not completely correct. 
The possibilities for more effective immunosup-
pression are discussed below, and it is upon such 
· advances that the next major jump in survival has 
· depended. The most important development has 
been the use of the new immunosuppressive 
agent, cyclosporin A. 
RESULTS 
D~1~D ~yD Conventional Immunosuppression 
The demonstration of its feasibility did not 
· make orthotopic liver transplantation a widely 
used clinical procedure; in fact, only we and Calne 
and Williams of England have persisted in large-
scale trials. By early summer of 1976, we had 
treated 111 consecutive patients. Of these recip-
ients, 31 (28%) had survived for at least 1 year 
(Table 35-3). Now, with follow-ups of 5.5 to 12 
years, 13 patients are still living. The flatness of the 
late-life survival curve has been an important 
stimulus for us to persist in these efforts, as has the 
very acceptable quality of life of these chronic sur-
vivors. Chronic graft rejection has been the single 
most common cause of late death. 
A second Colorado series of 30 patients was 
compiled in the subsequent 18 months, ending in 
early 1978. Of these patients, 50% survived for at 
least 1 year, and today, after 4 to almost 6 years, 13 
(43%) are still living (Table 35-3). It was thought 
t~at improvements in surgical technique (espe-
Cially biliary tract reconstruction), better diagnosis 
of postoperative hepatic dysfunction, and refine-
ments in immunosuppression were responsible for 
the better results. 
It is distressing to report that we were unable to 
~aintain these gains in a further series of 30 pa-
tients. Many of these last 30 patients, instead of 
ALG, had lymphoid depletion with thoracic duct 
drainage7 or lymphaphoresis. All 30 were given 
azathioprine and prednisone. The one-year survi-
val rate was only 33% (Table 35-3). Many of the 
early deaths in the last series were attributable to 
technical or management errors, as in the past. 
These misadventures often were not intrinsically 
lethal but became so because of the need for 
high-dose steroid therapy. 
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Cyc1osporin- Steroid 
Cyclosporin A is a new immunosuppressive 
agent that was first used clinically by Calne of 
Cambridge. We have used this agent in combina-
tion with low-dose steroid therapy for all liver re-
cipi~nts treated since March of 1980. 
At the University of Colorado, 14 patients were 
planned for such therapy. Two died during opera-
tion. Of the other 12, 11 lived for at least 1 year. 8 
Two died subsequently, one of a recurrent malig-
nancy and the other of recurrent Budd-Chiari 
syndrome. 
Twenty-three more patients have had similar 
therapy at the University of Pittsburgh. The first 4 
recipients were given poorly preserved livers and 
died. Of the next 19, 17 have survived with 
follow-ups of 1/2 to 6 months. 
The actuarial life survival curve of the combined 
Colorado and initial Pittsburgh experience is 
shown in Figure 35-10. There has been a strik-
ing improvement over our cumulative historical 
record. 
This great advance in immunosuppression 
should make feasible the much wider use of liver 
transplantation. 
FIG. 35-10. Data on the survival of liver transplant pa-
tients. ReCipients included 14 patients treated at the 
University of Colorado" and 15 treated at the University 
of Pittsburgh. Immunosuppression was with cyclospo-
rin A and steroids. Note the marked improvement of 
results in the group that received cyclosporin A over 
historical controls, in whom conventional immunosup-
pression was used. 
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